ONCOLYTICS BIOTECH INC's ticker is ONCYF and the CUSIP is 682310107. A total of 33 filers reported holding ONCOLYTICS BIOTECH INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $6,000 | 0.0% | 12,000 | 0.0% | 0.00% | – |
| Q2 2015 | $6,000 | -33.3% | 12,000 | 0.0% | 0.00% | – |
| Q1 2015 | $9,000 | +50.0% | 12,000 | 0.0% | 0.00% | – |
| Q4 2014 | $6,000 | -14.3% | 12,000 | 0.0% | 0.00% | – |
| Q3 2014 | $7,000 | -53.3% | 12,000 | 0.0% | 0.00% | – |
| Q2 2014 | $15,000 | -31.8% | 12,000 | 0.0% | 0.00% | – |
| Q1 2014 | $22,000 | +15.8% | 12,000 | 0.0% | 0.00% | – |
| Q4 2013 | $19,000 | -34.5% | 12,000 | 0.0% | 0.00% | – |
| Q3 2013 | $29,000 | – | 12,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXT Financial Group, Inc | 43,000 | $19,000 | 0.01% |
| VSR Financial Services, Inc. | 119,630 | $54,000 | 0.01% |
| TCI Wealth Advisors, Inc. | 1,200 | $1,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11,944 | $5,000 | 0.00% |
| STIFEL FINANCIAL CORP | 24,500 | $11,000 | 0.00% |
| FIRST MANHATTAN CO. LLC. | 1,000 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,000 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 38,529 | $18,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 44,017 | $20,000 | 0.00% |
| HOWE & RUSLING INC | 1,017 | $0 | 0.00% |